Title:
PHARMACEUTICAL COMBINATIONS FOR USE IN THE TREATMENT OF NEOPLASTIC DISEASES
Document Type and Number:
WIPO Patent Application WO/2023/113477
Kind Code:
A1
Abstract:
The present invention provides pharmaceutical combinations comprising (a) a TTK/PLK1 inhibitor (i.e. a compound of formula (I) or a pharmaceutically acceptable salt thereof as defend in the claims) and (b) a taxane anticancer drug or a pharmaceutically acceptable salt thereof (e.g. paclitaxel), as well as methods of using the combinations of the invention for the treatment of neoplastic diseases such as cancer.
Inventors:
LANE HEIDI (CH)
BACHMANN FELIX (CH)
LITHERLAND KARINE (CH)
MCSHEEHY PAUL (CH)
FORSTER-GROSS NICOLE (CH)
BACHMANN FELIX (CH)
LITHERLAND KARINE (CH)
MCSHEEHY PAUL (CH)
FORSTER-GROSS NICOLE (CH)
Application Number:
PCT/KR2022/020390
Publication Date:
June 22, 2023
Filing Date:
December 14, 2022
Export Citation:
Assignee:
SILLAJEN INC (KR)
International Classes:
A61K31/519; A61K31/337; A61K45/06; A61P35/00
Domestic Patent References:
| WO2019002542A1 | 2019-01-03 | |||
| WO2016166255A1 | 2016-10-20 |
Foreign References:
| US20170096432A1 | 2017-04-06 | |||
| US20190106422A1 | 2019-04-11 | |||
| US20130338133A1 | 2013-12-19 |
Attorney, Agent or Firm:
YOON & YANG (IP) LLC (KR)
Download PDF: